The AKT/ MCL-1 signaling pathway has been reported to play a prominent role in mediating antiapoptotic signals in chronic lymphocytic leukemia B cells [63] or in resistance to BCL-2/PARP inhibitors, or BH3 mimetics [64–66]. Here, BCL2 is linked to B-cell chronic lymphocytic leukemia.